Ansseau, E.;                     Vanderplanck, C.;                     Wauters, A.;                     Harper, S.Q.;                     Coppée, F.;                     Belayew, A.    
        Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD). Genes 2017, 8, 93.
    https://doi.org/10.3390/genes8030093
    AMA Style
    
                                Ansseau E,                                 Vanderplanck C,                                 Wauters A,                                 Harper SQ,                                 Coppée F,                                 Belayew A.        
                Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD). Genes. 2017; 8(3):93.
        https://doi.org/10.3390/genes8030093
    
    Chicago/Turabian Style
    
                                Ansseau, Eugénie,                                 Céline Vanderplanck,                                 Armelle Wauters,                                 Scott Q. Harper,                                 Frédérique Coppée,                                 and Alexandra Belayew.        
                2017. "Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD)" Genes 8, no. 3: 93.
        https://doi.org/10.3390/genes8030093
    
    APA Style
    
                                Ansseau, E.,                                 Vanderplanck, C.,                                 Wauters, A.,                                 Harper, S. Q.,                                 Coppée, F.,                                 & Belayew, A.        
        
        (2017). Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD). Genes, 8(3), 93.
        https://doi.org/10.3390/genes8030093